By downregulating the FGF10/BMP4 axis, the loss of TBX4 function may dysregulate the BMP/TGFβ/SMAD pathway and trigger the development of PAH by promoting cell proliferation [114]. The gene discussed is TBX4; the disease is pulmonary arterial hypertension.